FDA Commissioner Resignation Sparks Debate Over Mail-Order Abortion Drugs

The resignation of FDA Commissioner Dr. Marty Makary has prompted calls for the agency to re-evaluate its policies regarding mail-order abortion drugs. The article suggests this leadership transition provides a window for the administration to address current public health concerns.

We have not fully decoded this article yet, so read the full story at The Daily Wire.